22 May 2014 - FAB Researchers present at the Dieticians of Canada Omega-3 Symposium, Toronto

FAB Research scientists Dr Alex Richardson and Capt Joe Hibbeln will both be presenting some of the latest findings, along with other leading international omega-3 experts, at the ‘DHA / EPA Omega­3 for Health Symposium: Update 2014’ 

The Symposium will be held on Thursday, May 22, 2014 at the Mississauga Convention Center, Toronto, Ontario, organised by Professor Bruce Holub of the DHA/EPA Omega-3 Institute, and is aimed at helping professionals to distinguish the solid scientific evidence on omega-3 from the many media stories that often distort this.

It will cover recommended intakes of EPA/DHA omega-3 from national and international organizations for various health targets. Agri-food and nutraceutical sources will be explored in order to meet these targets. Controversial topics and marketing advertisements will also be objectively clarified.

Highlights include:

• the importance of higher DHA intakes during pregnancy, lactation, infancy and childhood
• the benefits of higher EPA/DHA intakes for complimentary care in inflammatory conditions
• the increased use of EPA/DHA for cardio care and risk factor management including triglyceride- and blood pressure-lowering
• EPA/DHA for age-related health conditions
• EPA/DHA for various mental disorders including depression and anxiety disorders
• EPA/DHA for the complimentary management of sports-related concussions

Topics:

• DHA Omega-3 Supplementation During Pregnancy Improves Health Outcomes
• Short- and Long-Term Benefits of DHA Intakes During Infancy
• DHA/EPA Omega-3 in Relation to Reading, Learning, and Behaviour in Healthy School Children and in ADHD
• Use of Omega-3 Fatty Acids for the Prevention and Management of Concussions and Traumatic Brain Injury
• Fish Consumption, Omega-3 Fatty Acid Status, and Association with Risk of Coronary Heart Disease and All-Cause Mortality
• A Role for Omega-3 Fatty Acids in Mental Disorders (incl. Depression, Violent Behaviours, others)
• Actual versus Target Intakes of DHA/EPA for Human Health and Disease Prevention/Management: Closing the Omega-3 Nutrition Gap with Agri-Foods and Nutraceuticals